Cargando…

Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson’s disease: Impact on late-onset neurodegenerative disease models

Parkinson’s disease (PD) affects almost 1% of the population worldwide over the age of 50 years. Exposure to environmental toxins like paraquat and rotenone is a risk factor for sporadic PD which constitutes 95% of total cases. Herbicide rotenone has been shown to cause Parkinsonian symptoms in mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayajuddin, Mohamad, Phom, Limamanen, Koza, Zevelou, Modi, Priyanka, Das, Abhik, Chaurasia, Rahul, Thepa, Abuno, Jamir, Nukshimenla, Neikha, Kelevikho, Yenisetti, Sarat Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398202/ https://www.ncbi.nlm.nih.gov/pubmed/36017079 http://dx.doi.org/10.3389/fnmol.2022.896183

Ejemplares similares

Fluorescence microscopy-based sensitive method to quantify dopaminergic neurodegeneration in a Drosophila model of Parkinson’s disease
por: Ayajuddin, Mohamad, et al.
Publicado: (2023)

Sexual dysfunction precedes motor defects, dopaminergic neuronal degeneration, and impaired dopamine metabolism: Insights from Drosophila model of Parkinson’s disease
por: Koza, Zevelou, et al.
Publicado: (2023)

Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview
por: SC, Yenisetti, et al.
Publicado: (2016)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Transcriptome Analysis of a Rotenone Model of Parkinsonism Reveals Complex I-Tied and -Untied Toxicity Mechanisms Common to Neurodegenerative Diseases
por: Cabeza-Arvelaiz, Yofre, et al.
Publicado: (2012)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Evidence of Oropharyngeal Dysfunction in Feeding in the Rat Rotenone Model of Parkinson's Disease
por: Gould, François D. H., et al.
Publicado: (2018)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
por: Niederberger, Ellen, et al.
Publicado: (2022)

Data on dose-dependent cytotoxicity of rotenone and neuroprotection conferred by Yashtimadhu (Glycyrrhiza glabra L.) in an in vitro Parkinson's disease model
por: Karthikkeyan, Gayathree, et al.
Publicado: (2021)

Excessive levels of nitric oxide in rat model of Parkinson’s disease induced by rotenone
por: XIONG, ZHONG-KUI, et al.
Publicado: (2015)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
por: Aurich, Mariana F., et al.
Publicado: (2017)

Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
por: Zhang, Yu, et al.
Publicado: (2019)

Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
por: Wang, Tian, et al.
Publicado: (2020)

Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease
por: Abhangi, Kinjal V, et al.
Publicado: (2022)

Neuroprotective effects of curcumin on the cerebellum in a rotenone‐induced Parkinson’s Disease Model
por: Fikry, Heba, et al.
Publicado: (2022)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Oleuropein confers neuroprotection against rotenone-induced model of Parkinson’s disease via BDNF/CREB/Akt pathway
por: Singh, Richa, et al.
Publicado: (2023)

Identification of Molecular Network Associated with Neuroprotective Effects of Yashtimadhu (Glycyrrhiza glabra L.) by Quantitative Proteomics of Rotenone-Induced Parkinson’s Disease Model
por: Karthikkeyan, Gayathree, et al.
Publicado: (2020)

Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models
por: Wang, Hongcai, et al.
Publicado: (2014)

Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease
por: Yuan, Jiawen, et al.
Publicado: (2016)

Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models
por: Liu, Lan-Xiang, et al.
Publicado: (2018)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
por: Zhang, Dongdong, et al.
Publicado: (2021)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson’s disease
por: El-Shamarka, Marwa El-Sayed, et al.
Publicado: (2023)

In vitro Models of Neurodegenerative Diseases
por: Slanzi, Anna, et al.
Publicado: (2020)

Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's Disease
por: Marella, Mathieu, et al.
Publicado: (2008)

The Pael-R gene does not mediate the changes in rotenone-induced Parkinson's disease model cells
por: Zou, Ting, et al.
Publicado: (2014)

Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson’s Disease
por: Murtaza, M., et al.
Publicado: (2016)

Effect of moxibustion on mTOR-mediated autophagy in rotenone-induced Parkinson's disease model rats
por: Wang, Shu-ju, et al.
Publicado: (2018)

Overexpression of Mitochondrial Ligases Reverses Rotenone-Induced Effects in a Drosophila Model of Parkinson’s Disease
por: Doktór, Bartosz, et al.
Publicado: (2019)

The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2020)

The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease
por: Landau, Regev, et al.
Publicado: (2022)

The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
por: Thomas Broome, Sarah, et al.
Publicado: (2022)

Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
por: Zaman, Vandana, et al.
Publicado: (2022)

Altitudinal and Seasonal Variation in Drosophila Species on Mount Japfu of Nagaland, a Sub-Himalayan Hilly State of India
por: Achumi, Bovito, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mrtmettv7tgcak994ikq94meoi